Press Releases and News

Landos Biopharma Recently Featured in BioCentury

May 18 2018

BioCentury is the news service of record for the biotechnology and pharmaceutical industry, and they recently covered Landos’ lead asset for Crohn’s and ulcerative colitis, BT-11.